Search research articles
Contact Us
Filters
Showing results (141-150 of 156) with videos related to
Page
of 16
Sort By:
Science Translational Medicine
|
January 18, 2022
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
Saborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2021
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Biorxiv : the Preprint Server for Biology
|
June 2, 2021
Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response
Saborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Science (New York, N.Y.)
|
February 20, 2025
Disease diagnostics using machine learning of B cell and T cell receptor sequences
Maxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
Cell Host & Microbe
|
December 3, 2021
Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia
Naranjargal J Dashdorj, Oliver F Wirz, Katharina Röltgen, et al.
JCI Insight
|
July 8, 2022
Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome
Xiaolin Jia, Shu Cao, Alexandra S Lee, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2022
Disease diagnostics using machine learning of immune receptors
Maxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
Nature
|
January 14, 2021
Local immune response to food antigens drives meal-induced abdominal pain
Javier Aguilera-Lizarraga, Morgane V Florens, Maria Francesca Viola, et al.
Cell
|
February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
Katharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Cell Reports. Medicine
|
July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 156) with videos related to
Sort By:
Page
of 16
Science Translational Medicine
|
January 18, 2022
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
Saborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2021
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Biorxiv : the Preprint Server for Biology
|
June 2, 2021
Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response
Saborni Chakraborty, Joseph C Gonzalez, Benjamin L Sievers, et al.
Science (New York, N.Y.)
|
February 20, 2025
Disease diagnostics using machine learning of B cell and T cell receptor sequences
Maxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
Cell Host & Microbe
|
December 3, 2021
Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia
Naranjargal J Dashdorj, Oliver F Wirz, Katharina Röltgen, et al.
JCI Insight
|
July 8, 2022
Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome
Xiaolin Jia, Shu Cao, Alexandra S Lee, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2022
Disease diagnostics using machine learning of immune receptors
Maxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
Nature
|
January 14, 2021
Local immune response to food antigens drives meal-induced abdominal pain
Javier Aguilera-Lizarraga, Morgane V Florens, Maria Francesca Viola, et al.
Cell
|
February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
Katharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Cell Reports. Medicine
|
July 15, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
Dorien Feyaerts, Julien Hédou, Joshua Gillard, et al.
Page
of 16